Stryker Mako vs Intuitive Surgical da Vinci Xi

Stryker Mako

The Stryker Mako is a robotic arm-assisted surgical system for total knee, partial knee, and total hip arthroplasty, using CT-based 3D pre-operative planning and real-time haptic boundary feedback to guide surgeons within planned cutting zones for precise implant positioning. Intraoperative bone tracking compensates for patient movement during surgery, maintaining accuracy throughout the procedure. With over 1,200 systems deployed globally and one of the longest clinical evidence records in orthopaedic robotics, Mako is the market leader in joint replacement robotic surgery. Used exclusively with Stryker orthopaedic implants. Hospital acquisition cost ranges from approximately $1M to $1.5M through Stryker's sales network.

Intuitive Surgical da Vinci Xi

The Intuitive Surgical da Vinci Xi is the world's most widely deployed robotic-assisted surgical system, enabling surgeons to perform complex minimally invasive procedures across multiple abdominal quadrants through four overhead-mounted robotic arms with EndoWrist instruments offering seven degrees of freedom. Featuring 3D HD visualisation at 10x magnification and motion scaling that eliminates hand tremor, the da Vinci Xi is FDA-cleared for general surgery, urology, gynaecology, thoracic, and cardiac procedures. With over 7,000 systems installed globally and more than 10 million procedures performed, it is the dominant robotic surgery platform worldwide. Hospital acquisition cost ranges from $1.5M to $2.5M with annual service contracts and per-procedure instrument costs of $700–$3,500.